Published in Lancet on December 11, 2011
Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects. J Am Coll Cardiol (2016) 1.45
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol (2014) 1.20
Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol (2012) 1.14
Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One (2013) 1.11
Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol (2014) 1.05
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J (2013) 1.03
Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation. PLoS One (2014) 0.94
National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare Part D beneficiaries. Ann Pharmacother (2013) 0.92
The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke. J Interv Card Electrophysiol (2013) 0.91
Diagnostic Performance of a Smartphone-Based Photoplethysmographic Application for Atrial Fibrillation Screening in a Primary Care Setting. J Am Heart Assoc (2016) 0.89
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). PLoS One (2015) 0.88
Continuation of dabigatran therapy in "real-world" practice in Hong Kong. PLoS One (2014) 0.88
The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation. J Biol Chem (2014) 0.87
Progress and challenges in the cardiovascular field. J Zhejiang Univ Sci B (2012) 0.83
Increased pulse pressure independently predicts incident atrial fibrillation in patients with type 2 diabetes. Diabetes Care (2012) 0.82
Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients. Card Electrophysiol Clin (2016) 0.82
Tutorial in oral antithrombotic therapy: biology and dental implications. Med Oral Patol Oral Cir Bucal (2013) 0.82
Prevalence of atrial fibrillation in patients with high CHADS2- and CHA2DS2VASc-scores: anticoagulate or monitor high-risk patients? Pacing Clin Electrophysiol (2014) 0.80
Prediction of atrial fibrillation development and progression: Current perspectives. World J Cardiol (2016) 0.80
Outcome of Circumferential Pulmonary Vein Isolation for Ablation of Atrial Fibrillation: A Single Center Experience. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.79
Clinical Differences between Subtypes of Atrial Fibrillation and Flutter: Cross-Sectional Registry of 407 Patients. Arq Bras Cardiol (2015) 0.79
Role of Circulating Fibrocytes in Cardiac Fibrosis. Chin Med J (Engl) (2016) 0.79
Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: a pilot study. PLoS One (2014) 0.79
Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update. Vasc Health Risk Manag (2013) 0.78
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. Eur J Clin Pharmacol (2012) 0.78
Nonalcoholic fatty liver disease as a multi-systemic disease. World J Gastroenterol (2016) 0.78
An atrial-fibrillation-linked connexin40 mutant is retained in the endoplasmic reticulum and impairs the function of atrial gap-junction channels. Dis Model Mech (2014) 0.78
Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety. Tex Heart Inst J (2012) 0.77
Updating the evidence for the effect of radiofrequency catheter ablation on left atrial volume and function in patients with atrial fibrillation: a meta-analysis. JRSM Open (2014) 0.77
Family history as a risk factor for recurrent hospitalization for lone atrial fibrillation: a nationwide family study in Sweden. BMC Cardiovasc Disord (2012) 0.77
Scarcity of atrial fibrillation in a traditional African population: a community-based study. BMC Cardiovasc Disord (2014) 0.77
Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol. BMJ Open (2015) 0.77
Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom. PLoS One (2013) 0.77
MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation. BMC Cardiovasc Disord (2015) 0.77
Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly? J Aging Res (2014) 0.76
Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care. Heart Lung Vessel (2014) 0.76
Comparison of the clinical features and outcomes in two age-groups of elderly patients with atrial fibrillation. Clin Interv Aging (2014) 0.76
The Abundance of Epicardial Adipose Tissue Surrounding Left Atrium Is Associated With the Occurrence of Stroke in Patients With Atrial Fibrillation. Medicine (Baltimore) (2016) 0.76
Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation. J Pharmacol Pharmacother (2014) 0.75
The atrial fibrillation epidemic is approaching the physician's door: will mobile technology improve detection? BMC Med (2014) 0.75
Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population. PLoS One (2017) 0.75
A case of central diabetes insipidus associated with cardiac dysfunction. Clin Case Rep (2016) 0.75
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy. J Am Soc Echocardiogr (2016) 0.75
Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation in the Asia-Pacific region: a phase 3 randomized controlled trial. J Cardiovasc Pharmacol (2016) 0.75
Tachycardia-induced cardiomyopathy. BMJ Case Rep (2012) 0.75
Use of an interdisciplinary, participatory design approach to develop a usable patient self-assessment tool in atrial fibrillation. Patient Prefer Adherence (2013) 0.75
Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis. BMC Cardiovasc Disord (2017) 0.75
Rac1 GTPase Regulates 11β Hydroxysteroid Dehydrogenase Type 2 and Fibrotic Remodeling. J Biol Chem (2017) 0.75
Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case. PLoS One (2016) 0.75
The significance of the left atrial volume index in prediction of atrial fibrillation recurrence after electrical cardioversion. J Cardiovasc Thorac Res (2017) 0.75
Minimally Invasive Atrial Fibrillation Surgery: Hybrid Approach. Methodist Debakey Cardiovasc J (2016) 0.75
The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia. Malays J Med Sci (2012) 0.75
Processes and Recommendations for Creating mHealth Apps for Low-Income Populations. JMIR Mhealth Uhealth (2017) 0.75
Serum levels of nicotinamide-adenine dinucleotide phosphate oxidase 4 are associated with non-valvular atrial fibrillation. Biomed Rep (2015) 0.75
The Association between Arrhythmia and Helicobacter pylori Infection: A Meta-Analysis of Case-Control Studies. Int J Environ Res Public Health (2016) 0.75
Patient-Centred Care of Older Adults With Cardiovascular Disease and Multiple Chronic Conditions. Can J Cardiol (2016) 0.75
Identification of antithrombotic drugs related to total joint replacement using anonymised free-text notes: a search strategy in the Clinical Practice Research Datalink. BMJ Open (2015) 0.75
Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study. BMC Cardiovasc Disord (2016) 0.75
Adjunctive surgical atrial fibrillation ablation during cardiac surgery: real life experiences. Herzschrittmacherther Elektrophysiol (2015) 0.75
Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events. Ther Adv Drug Saf (2017) 0.75
The involvement of pharmacies in the screening of undiagnosed atrial fibrillation. Intern Emerg Med (2017) 0.75
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29
Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med (2012) 4.69
Genomic instability in laminopathy-based premature aging. Nat Med (2005) 4.54
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol (2012) 3.55
Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension (2010) 2.39
The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest (2012) 2.33
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thromb Haemost (2011) 2.22
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. Thromb Haemost (2011) 2.01
Overexpression of HCN-encoded pacemaker current silences bioartificial pacemakers. Heart Rhythm (2008) 1.61
Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias. Arthritis Rheum (2011) 1.54
Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study. J Hypertens (2012) 1.51
Treatment of atrial fibrillation with an implantable atrial defibrillator--long term results. Eur Heart J (2003) 1.46
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". Thromb Haemost (2009) 1.40
Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol (2010) 1.28
Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. J Am Coll Cardiol (2011) 1.27
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients? Am J Med (2010) 1.24
Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol (2010) 1.17
Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial. PLoS One (2013) 1.09
Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2013) 1.08
Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients. Thromb Haemost (2009) 1.04
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med (2008) 1.03
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. Cochrane Database Syst Rev (2013) 1.03
Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients. J Am Coll Cardiol (2012) 1.00
Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study. J Am Heart Assoc (2013) 0.97
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial. Eur Heart J (2013) 0.97
Stroke and thromboembolism in atrial fibrillation. Circ J (2012) 0.95
Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study. Am J Med (2012) 0.94
Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project. Circ Arrhythm Electrophysiol (2012) 0.93
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. Clin Res Cardiol (2014) 0.92
Utilization of lipid lowering medications among adults in the United States 1999-2006. Atherosclerosis (2009) 0.91
Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. Int J Cardiol (2012) 0.91
Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress. Cardiovasc Diabetol (2012) 0.91
Increased levels of circulating endothelial progenitor cells in subjects with moderate to severe chronic periodontitis. J Clin Periodontol (2009) 0.90
Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263]. BMC Med Res Methodol (2005) 0.89
Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke. Can J Cardiol (2013) 0.88
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb Haemost (2010) 0.88
Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent. J Hypertens (2007) 0.88
Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more). Clin Cardiol (2014) 0.87
Functional consequences of overexpressing the gap junction Cx43 in the cardiogenic potential of pluripotent human embryonic stem cells. Biochem Biophys Res Commun (2008) 0.86
Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis. Patient Educ Couns (2012) 0.86
Association between raised blood pressure and dysglycemia in Hong Kong Chinese. Diabetes Care (2008) 0.86
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Eur J Heart Fail (2012) 0.85
Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors. Stroke (2007) 0.85
TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT). BMC Cardiovasc Disord (2010) 0.84
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Thromb Haemost (2012) 0.84
Insights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) registry. Am J Cardiol (2011) 0.84
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. Clin Res Cardiol (2011) 0.84
Atrial fibrillation management in Asia: from the Asian expert forum on atrial fibrillation. Int J Cardiol (2012) 0.83
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey. Thromb Haemost (2012) 0.83
Apixaban compared with warfarin for stroke prevention in atrial fibrillation: implications of time in therapeutic range. Circulation (2013) 0.82
Leukocytosis and clinical outcomes in acute inferior myocardial infarction. Int J Cardiol (2006) 0.82
Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers? Ann Med (2007) 0.82
The ATRIA risk scheme to predict warfarin-associated hemorrhage not ready for clinical use. J Am Coll Cardiol (2012) 0.82
Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers. PLoS One (2012) 0.81
Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" prediction. Circ J (2014) 0.81
Effect of periodontal treatment on circulating CD34(+) cells and peripheral vascular endothelial function: a randomized controlled trial. J Clin Periodontol (2010) 0.81
Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants. Thromb Haemost (2016) 0.80
Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. Eur J Clin Invest (2013) 0.80
Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong. Adv Ther (2012) 0.80
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. J Hypertens (2011) 0.80
Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project. Eur J Heart Fail (2012) 0.79
Best practice for atrial fibrillation patient education. Curr Pharm Des (2015) 0.79
Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk. Lancet Neurol (2010) 0.79
Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study. Chest (2013) 0.79
Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study. Metab Syndr Relat Disord (2014) 0.79
Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint. Europace (2010) 0.79
Maintaining therapeutic anticoagulation: the importance of keeping "within range". Chest (2007) 0.79
An epidemic of atrial fibrillation? Europace (2011) 0.79
Interatrial mechanical dyssynchrony worsened atrial mechanical function in sinus node disease with or without paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2009) 0.78
Atrial fibrillation and stroke risk prevention in real-life clinical practice. Thromb Haemost (2009) 0.78
Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review. Am J Med (2009) 0.78
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest (2007) 0.78
The assessment of stroke and bleeding risk in atrial fibrillation: where are we now? Expert Rev Cardiovasc Ther (2010) 0.78
Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction. Ann Med (2009) 0.78
Type A aortic intramural hematoma: clinical features and outcomes in Chinese patients. Clin Cardiol (2011) 0.77
A-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium. ACS Chem Neurosci (2012) 0.77
Alcohol intake and prognosis of atrial fibrillation. Heart (2013) 0.77
Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. Age Ageing (2011) 0.77
Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation--focus on the elderly. Circ J (2013) 0.77
Atrial fibrillation and mortality: the impact of antithrombotic therapy. Eur Heart J (2010) 0.77
The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study. Chest (2014) 0.77
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood. J Thromb Thrombolysis (2006) 0.77
Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study. Thromb Haemost (2014) 0.76
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores. Age Ageing (2010) 0.76
Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention. Cardiovasc Diabetol (2011) 0.76
Comparison of perindopril versus captopril for treatment of acute myocardial infarction. Am J Cardiol (2002) 0.76
Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. Blood Coagul Fibrinolysis (2009) 0.76